MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 11..20 of 27 - per page Previous page Next page
Order by
A series of substituted 3,6-diphenyl-7H-[1,2,4] triazolo[3,4-b] [1,3,4] thiadiazines that act as inhibitors of PDE4 More
Provision of access to DNA samples of 16 common diseases to conduct association studies of specific single nucleotide polymorphisms (SNPs) and specific diseases More
Grb2 SH2 domain signaling antagonists with enhanced binding affinity. More
Administration of B11 peptide reduced pathologies in various inflammatory models: septic shock, colitis (-TNBS, DSS models), allergy (allergic peritonitis, allergic asthma) and changed cytokines profiles indicating immunomodulatory properties. The... More
A novel agonist that is selective for the mouse A3AR while retaining selectivity for the human receptor. More
New substituted phenyl compounds useful for the treatment of respiratory disorders e.g. extrinsic or intrinsic or atopic asthma, chronic bronchitis, bronchiectasis and emphysema - multifunctional ?-agonist compounds comprising a reactive oxygen... More
Diagnostics_ CD48 is involved in chemokine expression and eosinophil recruitment. Therefore, CD48 probably has an important role for orchestrating innate and adaptive responses in allergic lung inflammatory responses. patent only in US Babyseed... More
Provocholine® (methacholine chloride) is indicated for the diagnosis of bronchial airway hyperresponsiveness in subjects suspected of having asthma. The methacholine challenge test with Provocholine® provides a measure of the severity of asthma. More
The laboratory is active in the field of allergy and immunopharmacology of inflammation More
Lead Inventor: Charles Emala, M.D. The Challenge/ Problem/ Unmet Need: Millions of Americans suffer from asthma and chronic obstructive pulmonary disease (COPD) and bronchoconstrictive diseases have increased in frequency and associate mortality... More
Displaying 11..20 of 27 - per page Previous page Next page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioTrinity
ShareVault
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us